Mesoblast (MESO) Enterprise Value (2015 - 2025)

Mesoblast has disclosed Enterprise Value across 11 years of filings, most recently posting -$130.0 million for Q4 2025.

• Enterprise Value for Q4 2025 came in at -$130.0 million, down 241.78% year-over-year; the trailing twelve-month figure through Dec 2025 was -$130.0 million (down 241.78% YoY), and the FY2025 annual result was -$161.6 million, down 156.59% from the prior year.
• Enterprise Value came in at -$130.0 million for Q4 2025 at Mesoblast, up from -$161.6 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$38.0 million in Q4 2024 to a low of -$161.6 million in Q2 2025.
• The 5-year median for Enterprise Value is -$77.6 million (2023), against an average of -$92.4 million.
• Across the five-year window, Enterprise Value jumped 55.84% in 2022 and slumped 241.78% in 2025, its largest moves.
• Mesoblast's Enterprise Value stood at -$94.8 million in 2021, then grew by 28.71% to -$67.6 million in 2022, then retreated by 14.69% to -$77.6 million in 2023, then soared by 50.96% to -$38.0 million in 2024, then plunged by 241.78% to -$130.0 million in 2025.
• The last three Enterprise Value figures came in at -$130.0 million (Q4 2025), -$161.6 million (Q2 2025), and -$38.0 million (Q4 2024), per Business Quant data.